We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bivigam

News List

ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM(R) and NABI-HB(R) americanpharmaceuticalreview
August 11, 2021
ADMA Biologics Inc. announced the commercial availability of additional vial sizes of BIVIGAM and NABI-HB, which are currently in stock and commercially available to U.S healthcare providers and patients.
FDA Approves ADMA Biologics Increased IVIG Production contractpharma
April 29, 2021
ADMA Biologics, Inc., a commercial biopharmaceutical company dedicated to specialty plasma-derived biologics, received approval from the U.S. FDA for the company’s expanded manufacturing process, enabling fractionation and purification of a ...
ADMA Announces It Will Reintroduce Bivigam Into the Market drugs
May 17, 2019
ADMA Announces It Will Reintroduce Bivigam Into the Market.